Skip to main content

Table 1 Characteristics of participants with HCV Core-E1 sequences in the ALIVE cohort

From: Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore

Characteristic

Total (%)

(n = 508)

Age, years (median [IQR])

53.9 (46.8–59.3)

Black race

441 (86.8)

Male sex

345 (67.9)

Female sex

163 (32.1)

High school education or higher

202 (39.8)

Homelessnessa

98 (19.3)

Incarcerated ≥1 weeka

51 (10.1)

HCV Genotype

 1a

421 (82.9)

 1b

87 (17.1)

HIV positive at baseline

167 (32.9)

HIV seroconverted (baseline to most recent visit)

29 (5.7)

HIV positive at most recent visit

196 (38.6)

Most recent HIV RNA among HIV infectedb

 HIV RNA < 400 copies/ml

111 (56.6)

 HIV RNA ≥ 400 copies/ml

51 (26.0)

Prescribed methadone or buprenorphine

176 (34.7)

Injection drug use behaviors

 Years injecting (mean [SD])

12.68 (10.8)

 Ever shared a syringe at baseline

451 (89.1)

 Injected drugsa

204 (40.2)

 Shared syringea

85 (16.7)

 Used cracka

157 (31.0)

 Injected or snorted cocainea

112 (22.1)

 Injected heroina

146 (28.7)

 Snorted heroina

85 (16.7)

 Injected speedballa

122 (24.0)

 Visited SSP in the last month

61 (12.1)

  1. aWithin 6 months of visit
  2. bHIV RNA unavailable in 34 HIV infected patients
  3. HCV hepatitis c virus, SSP syringe service program, HIV human immunodeficiency virus, RNA ribonucleic acid, IQR interquartile range, SD standard deviation